Making an Impact Where It Matters Most

  • Over 350 million people worldwide live with rare diseases. Yet only 5% have approved treatments.
  • At Nuvamid, we are deeply committed to transforming the lives of patients and families affected by rare and orphan diseases. These conditions, often overlooked due to their low prevalence, present significant medical challenges with few or no effective treatment options. 

  • Our mission is to bridge this gap by focusing our resources, innovation, and expertise on developing therapies for these underserved communities. We recognize that every patient’s journey is unique, and for those living with orphan diseases, time is critical.

  • Nucleotides represent a unique opportunity to address the cellular root of many rare diseases, transforming lives through science.